India approves AstraZeneca's Covid-19 vaccine

It is the first Covid-19 vaccine to be approved for emergency use in the country, which has the highest number of infections after the United States

India has approved the Covid-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world’s second most populous country.

Information and Broadcasting Minister Prakash Javadekar told reporters on Saturday the vaccine had been approved on Friday.

It is the first Covid-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the US.

Mr Javadekar said at least three more vaccines were waiting in line to be approved.

“India is perhaps the only country where at least four vaccines are getting ready,” he said.

“One was approved yesterday for emergency use, Serum’s Covishield,” he said, referring to the Serum Institute of India, which is producing that shot.

India has reported more than 10 million Covid-19 cases, though its rate of infection has come down significantly from a mid-September peak.

The country hopes to inoculate 300 million of its 1.36 billion people in the first six to eight months of 2021.

EDITOR'S PICKS
NEWSLETTERS